Tocilizumab for the treatment of systemic onset JIA: a single centre experience from India
Saved in:
Main Authors: | Sawhney Sujata (Author), Aggarwal Manjari (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
by: Joly J, et al.
Published: (2011) -
Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre
by: Livermore P, et al.
Published: (2008) -
Factors impacting referral of JIA patients to a tertiary level pediatric rheumatology center in North India: a retrospective cohort study
by: Manjari Agarwal, et al.
Published: (2020) -
Experience of the Tocilizumab Application in Systemic Onset Juvenile Arthritis
by: A. V. Krasnopol'skaja, et al.
Published: (2015) -
2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
by: Yokota S, et al.
Published: (2008)